ComplyRx

Cardiometabolic & renal · Live ClinicalTrials.gov data

Empagliflozin (Jardiance) clinical trial pipeline

The timeline below tracks the 16 largest phase 2–4 empagliflozin (Jardiance) trials on ClinicalTrials.gov by enrolment, 4 of them actively recruiting. The next phase 3 primary completion among them is expected Feb 2029. Refreshed daily. Add up to four competitors to compare pipelines side by side.

16+

Major trials tracked

5

Phase 3 trials

4

Actively recruiting

Feb 2029

Next phase 3 primary completion

11,144

Participants across trials

Boehringer Ingelheim

Lead sponsor by trial count

empagliflozin (16)8 active2008–2031
empagliflozin
Key
Actual date
Anticipated
Forecast to primary completion
RecruitingCompletedUnknown status
'08
'10
'12
'14
'16
'18
'20
'22
'24
'26
'28
'30
empagliflozin
BI 10773 add-on to Metformin in Patients With Type 2 DiabetesP2
Empagliflozin as Adjunctive to InSulin thErapy Over 52 Weeks in Patients With Type 1 Diabetes Mellitus (EASE-2)P3
Diabetes Study of Linagliptin and Empagliflozin in Children and Adolescents (DINAMO)TMP3
BEYONDP4
Comparison of Empaglifozin and Vildagliptin in Type 2 Diabetes MellitusP4
MIRACLEP3
Study to Evaluate MET409 Alone or in Combination With Empagliflozin in Patients With Type 2 Diabetes and NASHP2
EMPA-HEART 2P4
VETAP3
SGLT2i VS ACEiP2
Effect of Empagliflozin and Dulaglutide on MAFLD in Patients With T2DP4
ENVELOPP4
Pioglitazone and Empagliflozin for Fatty Liver Disease in Type 2 DiabetesP4
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the HeartP3
EMPA-BPP4
GLYCO-3PP4

Upcoming readouts

3 ahead · empagliflozin

Select a trial to load its full ClinicalTrials.gov record.

Key empagliflozin trials

Top 12 of the 16 tracked phase 2–4 trials, ordered by phase and status. Trial names open the full ComplyRx trial page; NCT ids link to ClinicalTrials.gov.

TrialTitlePhaseStatusPrimary completion
NCT06862739GLYCO-3P: Glycemic Control With Triple Pathway Approach Through Empagliflozin, Linagliptin and Metformin C…Phase 4RecruitingApr 2026
NCT06989723Pioglitazone and Empagliflozin for Fatty Liver Disease in Type 2 DiabetesPhase 4RecruitingDec 2026
NCT06642623ENVELOP: A Prospective Trial of Enavogliflozin to Evaluate Cardio-renal Outcome in Type 2 Diabetes Mellit…Phase 4RecruitingSept 2029
NCT04196231BEYOND: Durability of Combination of Insulin and GLP-1 Receptor Agonist or SGLT-2 Inhibitors Versus Basa…Phase 4CompletedSept 2020
NCT05359432Comparison of Empaglifozin and Vildagliptin in Type 2 Diabetes MellitusPhase 4CompletedAug 2021
NCT04461041EMPA-HEART 2: Empagliflozin and Cardiac Remodelling in People Without DiabetesPhase 4CompletedJul 2022
NCT07541456EMPA-BP: Empagliflozin Versus Non-SGLT2 Oral Drugs for Blood Pressure in Type 2 DiabetesPhase 4CompletedNov 2025
NCT05140694Effect of Empagliflozin and Dulaglutide on MAFLD in Patients With T2DPhase 4UnknownJun 2024
NCT06935370A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People W…Phase 3RecruitingFeb 2029
NCT02414958Empagliflozin as Adjunctive to InSulin thErapy Over 52 Weeks in Patients With Type 1 Diabetes Me…Phase 3CompletedApr 2017
NCT03429543Diabetes Study of Linagliptin and Empagliflozin in Children and Adolescents (DINAMO)TMPhase 3CompletedOct 2022
NCT04271189MIRACLE: Managing DIabetes Remission After Combined Therapy in EarLy Stage of DiabetEsPhase 3CompletedAug 2024

Track empagliflozin with ComplyRx

Get an alert when a trial changes status, moves its completion date, or a new trial registers in scope. Checked nightly against ClinicalTrials.gov.

Track empagliflozin

Related drug pipelines

Compare empagliflozin vs dapagliflozinCompare empagliflozin vs finerenone

FAQ

How many clinical trials are running for empagliflozin?
ClinicalTrials.gov lists more than 16 phase 2–4 empagliflozin trials. This page tracks the 16 largest by enrolment: 3 phase 2, 5 phase 3, and 8 phase 4 among them, with 4 actively recruiting. Updated daily.
Are there clinical trials for Jardiance?
Jardiance is the brand name for empagliflozin, so empagliflozin trials on ClinicalTrials.gov cover it. ClinicalTrials.gov lists more than 16 phase 2–4 empagliflozin trials. This page tracks the 16 largest by enrolment: 3 phase 2, 5 phase 3, and 8 phase 4 among them, with 4 actively recruiting. Updated daily.
Where does this data come from?
All trial data is sourced from ClinicalTrials.gov (CTGov) and refreshed on this page daily.
Can I compare empagliflozin against other drugs?
Yes. The free ComplyRx Trial Pipeline tool compares up to five drugs side by side on one timeline, with PNG and PDF export. Add any competitor in the search box above.
Join the waitlist

Be the first to access ComplyRx

We'll let you know as soon as your spot opens to use ComplyRx.

By joining, you agree to our Privacy Policy.